课题基金 / 基金详情

Does Human Betaretrovirus (HBRV) infection predate the development of Breast Cancer?

Does Human Betaretrovirus (HBRV) infection predate the development of Breast Cancer?
人类乙逆转录病毒 (HBRV) 感染是否早于乳腺癌的发生?
批准号:
436860
负责人:
Mason Andrew L
金额:
$10.93万
依托单位:
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2020
资助国家:
加拿大
项目状态:
已结题
起止时间:
2020-10-01 至 2021-10-01

项目摘要

项目成果

Mason Andrew L的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Betaretroviruses are known to cause mammalian breast cancer but the role these agents play in human disease is unknown. Patients with breast cancer have been shown to have antibody reactivity to a characterized human betaretrovirus (HBRV). To study if HBR
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Translational studies to test potential therapies for patients with primary biliary cirrhosis
  • 批准号:
    304870
  • 项目类别:
    Operating Grants
  • 资助金额:
    $55.95万
  • 财政年份:
    2014
  • 负责人:
    Mason Andrew L
  • 依托单位:
Interaction of the Microbiome and Genetic Architecture in Chronic Immune Mediated Hepatobiliary Diseases
  • 批准号:
    276974
  • 项目类别:
    Operating Grants
  • 资助金额:
    $0.87万
  • 财政年份:
    2012
  • 负责人:
    Mason Andrew L
  • 依托单位:
Isolation of a novel human retrovirus associated with primary biliary cirrhosis and fulfillment of koch's postulates in vitro
  • 批准号:
    223288
  • 项目类别:
    Operating Grants
  • 资助金额:
    $31.05万
  • 财政年份:
    2011
  • 负责人:
    Mason Andrew L
  • 依托单位:
Pilot study of highly active anti-retroviral therapy for patients with primary biliary cirrhosis
  • 批准号:
    223750
  • 项目类别:
    Operating Grants
  • 资助金额:
    $36.88万
  • 财政年份:
    2011
  • 负责人:
    Mason Andrew L
  • 依托单位:
海外基金